FEDERAL WAY, Wash., April 24, 2018 /PRNewswire-USNewswire/ -- The Institute for Functional Medicine (IFM) has taken another
This development, combined with the recent appointment of Amy R. Mack as the new chief executive officer (CEO) and the ascension of former CEO Laurie Hofmann, MPH, to chairman of the board, enables the organization to better address a broader agenda beyond education—including researching innovative and economic clinical models and broad-based strategic partnerships.
Dr. Sennett, a board certified internist and fellow of the American College of Physicians (FACP), comes to IFM from a long career in health care as a practitioner and administrator, most recently as president and CEO at the Asthma and Allergy Foundation of America. He received his PhD in health policy and management from MIT, his MD and MPhil (in human genetics) from Yale, and his BS in biology from Stanford.
"As a healthcare professional for over 30 years, my personal mission has always been to provide healthcare solutions for patients that effectively treat their conditions at a cost that makes quality health care accessible and affordable," says Dr. Sennett. "We are at a critical time in our country where the cost of our healthcare system substantially outweighs the value and positive outcomes it provides the average patient. What drew me to IFM—and more generally to Functional Medicine—is the evidence that Functional Medicine provides a path forward to create an affordable healthcare model based on individualized, patient-centered care that delivers optimal results in addressing chronic diseases and restoring health."
Dr. Sennett's immediate priorities include enhancing the Functional Medicine evidence base and continuing to drive greater accessibility and innovation of the organization's educational programs in alignment with IFM's strategic plan. He will also accelerate IFM's online learning capability and outcomes research programs to strengthen the evidence base for Functional Medicine.
"We are excited Dr. Sennett is joining our team at this critical moment for Functional Medicine. His expertise is required as IFM builds on its already strong foundation as best in class educator and innovator in Functional Medicine and reinforces its role in shaping health care in the United States and around the world," says Mack. "Dr. Sennett will play an integral role in catalyzing the evidence base and research to demonstrate Functional Medicine's effectiveness in identifying and treating the root cause of chronic conditions and diseases and proving both the clinical and economic value for patients."
"Our strong foundation and 25-year track record as the leader in Functional Medicine, combined with our expanded executive team, will propel IFM to more aggressively support and grow vital partnerships across academic medicine, health systems, self-insured employers, and educational coalitions," says Hofmann. "This will facilitate broader and faster adoption of Functional Medicine as an important and much-needed component in promoting health and reversing the epidemic of chronic disease."
About The Institute for Functional Medicine (IFM): IFM is the global leader in Functional Medicine. The mission of IFM is to serve the highest expression of individual health through the widespread adoption of Functional Medicine. For more information about IFM, please visit IFM.org.
Functional Medicine is a personalized, systems-oriented model that empowers patients and practitioners to achieve the highest expression of health by working in collaboration to address the underlying causes of disease. The primary drivers of the chronic disease epidemic are the daily interactions among an individual's genetics, environment, and lifestyle choices. Functional Medicine addresses these underlying causes of disease and equips healthcare practitioners to help their patients manage this complex, interconnected web. For more information about Functional Medicine, please visit IFM.org.
View original content:http://www.prnewswire.com/news-releases/the-institute-for-functional-medicine-expands-leadership-team-to-address-the-worldwide-epidemic-of-chronic-disease-300635895.html
SOURCE Institute for Functional Medicine
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All